BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

931 related articles for article (PubMed ID: 17334510)

  • 1. Platelet microparticle membranes have 50- to 100-fold higher specific procoagulant activity than activated platelets.
    Sinauridze EI; Kireev DA; Popenko NY; Pichugin AV; Panteleev MA; Krymskaya OV; Ataullakhanov FI
    Thromb Haemost; 2007 Mar; 97(3):425-34. PubMed ID: 17334510
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The majority of circulating platelet-derived microparticles fail to bind annexin V, lack phospholipid-dependent procoagulant activity and demonstrate greater expression of glycoprotein Ib.
    Connor DE; Exner T; Ma DD; Joseph JE
    Thromb Haemost; 2010 May; 103(5):1044-52. PubMed ID: 20390225
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Platelet-derived microparticles during and after acute coronary syndrome.
    Skeppholm M; Mobarrez F; Malmqvist K; Wallén H
    Thromb Haemost; 2012 Jun; 107(6):1122-9. PubMed ID: 22371053
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Flow cytometric detection and procoagulant activity of circulating canine platelet-derived microparticles.
    Helmond SE; Catalfamo JL; Brooks MB
    Am J Vet Res; 2013 Feb; 74(2):207-15. PubMed ID: 23363344
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of activated platelets in canine blood by use of flow cytometry.
    Wills TB; Wardrop KJ; Meyers KM
    Am J Vet Res; 2006 Jan; 67(1):56-63. PubMed ID: 16426212
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of the procoagulant activity of microparticle-associated phosphatidylserine using XACT.
    Connor DE; Exner T; Ma DD; Joseph JE
    Blood Coagul Fibrinolysis; 2009 Oct; 20(7):558-64. PubMed ID: 19593114
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Platelet activation as a marker for in vivo prothrombotic activity: detection by flow cytometry.
    Tomer A
    J Biol Regul Homeost Agents; 2004; 18(2):172-7. PubMed ID: 15471223
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thrombogenesis in sickle cell disease.
    Tomer A; Harker LA; Kasey S; Eckman JR
    J Lab Clin Med; 2001 Jun; 137(6):398-407. PubMed ID: 11385360
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The procoagulant properties of hyaluronic acid-collagen (I)/chitosan complex film.
    Hu Y; Wu Y; Cai J; Ma S; Wang X
    J Biomater Sci Polym Ed; 2009; 20(7-8):1111-8. PubMed ID: 19454172
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development and assessment of enzyme immunoassay for platelet-derived microparticles.
    Osumi K; Ozeki Y; Saito S; Nagamura Y; Ito H; Kimura Y; Ogura H; Nomura S
    Thromb Haemost; 2001 Feb; 85(2):326-30. PubMed ID: 11246556
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Strenuous exercise promotes shear-induced thrombin generation by increasing the shedding of procoagulant microparticles from platelets.
    Chen YW; Chen JK; Wang JS
    Thromb Haemost; 2010 Aug; 104(2):293-301. PubMed ID: 20589321
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinically apparent atherosclerotic disease in diabetes is associated with an increase in platelet microparticle levels.
    Tan KT; Tayebjee MH; Lim HS; Lip GY
    Diabet Med; 2005 Dec; 22(12):1657-62. PubMed ID: 16401308
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro effects of detergent sclerosants on coagulation, platelets and microparticles.
    Parsi K; Exner T; Connor DE; Ma DD; Joseph JE
    Eur J Vasc Endovasc Surg; 2007 Dec; 34(6):731-40. PubMed ID: 17919946
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Merocyanine 540 as a fluorescent probe of altered membrane phospholipid asymmetry in activated whole blood platelets.
    Watala C; Waczulikova I; Wieclawska B; Rozalski M; Gresner P; Gwoździński K; Mateasik A; Sikurova L
    Cytometry; 2002 Nov; 49(3):119-33. PubMed ID: 12442312
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protein S and factor V in regulation of coagulation on platelet microparticles by activated protein C.
    Somajo S; Koshiar RL; Norström E; Dahlbäck B
    Thromb Res; 2014 Jul; 134(1):144-52. PubMed ID: 24835672
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating platelet-derived microparticles in systemic lupus erythematosus. Association with increased thrombin generation and procoagulant state.
    Pereira J; Alfaro G; Goycoolea M; Quiroga T; Ocqueteau M; Massardo L; Pérez C; Sáez C; Panes O; Matus V; Mezzano D
    Thromb Haemost; 2006 Jan; 95(1):94-9. PubMed ID: 16543967
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyclosporine enhances platelet procoagulant activity.
    Tomasiak M; Rusak T; Gacko M; Stelmach H
    Nephrol Dial Transplant; 2007 Jun; 22(6):1750-6. PubMed ID: 17308321
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Silver nanoparticles enhance thrombus formation through increased platelet aggregation and procoagulant activity.
    Jun EA; Lim KM; Kim K; Bae ON; Noh JY; Chung KH; Chung JH
    Nanotoxicology; 2011 Jun; 5(2):157-67. PubMed ID: 20822370
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of platelet activation on the hypercoagulability induced by murine monoclonal antiphospholipid antibodies.
    Membre A; Wahl D; Latger-Cannard V; Max JP; Lacolley P; Lecompte T; Regnault V
    Haematologica; 2008 Apr; 93(4):566-73. PubMed ID: 18322249
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The involvement of Na+/K(+)-ATPase in the development of platelet procoagulant response.
    Tomasiak M; Stelmach H; Rusak T; Ciborowski M; Radziwon P
    Acta Biochim Pol; 2007; 54(3):625-39. PubMed ID: 17653302
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 47.